Pre-order Enquiry
Request Free Sample
Global Classical Swine Fever Vaccines Market Research Report 2021
SKU ID : QYR-17095387 | Publishing Date : 06-Jan-2021 | No. of pages : 124
Request Sample
Request Customization
Check Discounts
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The classification of Classical Swine Fever Vaccines includes Tissue Culture Origin and Cell Line Origin. The proportion of Tissue Culture Origin in 2016 is about 60%. And the proportion of Cell Line Origin in 2016 is about 40%. Market competition is intense WINSUN, CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Classical Swine Fever Vaccines industry will be more and more popular in the future.
The global Classical Swine Fever Vaccines market was valued at US$ 144 million in 2019 and is expected to reach US$ 173.8 million by the end of 2026, growing at a CAGR of 2.7% during 2021-2026.
This report focuses on Classical Swine Fever Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Classical Swine Fever Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Classical Swine Fever Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Source
Tissue Culture Origin
Cell Line Origin
Segment by Sales Channel
Government Tender
Market Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
WINSUN
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
The classification of Classical Swine Fever Vaccines includes Tissue Culture Origin and Cell Line Origin. The proportion of Tissue Culture Origin in 2016 is about 60%. And the proportion of Cell Line Origin in 2016 is about 40%. Market competition is intense WINSUN, CAHIC, Merial, MSD Animal Health, Chopper Biology, Ceva etc. are the leader of this industry. With the development of society and the changing of consumer demand, the Classical Swine Fever Vaccines industry will be more and more popular in the future.
The global Classical Swine Fever Vaccines market was valued at US$ 144 million in 2019 and is expected to reach US$ 173.8 million by the end of 2026, growing at a CAGR of 2.7% during 2021-2026.
This report focuses on Classical Swine Fever Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Classical Swine Fever Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Classical Swine Fever Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Source
Tissue Culture Origin
Cell Line Origin
Segment by Sales Channel
Government Tender
Market Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
WINSUN
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
